A former Israel Defense Forces medic who is now the chief

New Post Public Reply Private Reply Replies (0) Message Board
someconcerns Drano #408
372
Quote:
A former Israel Defense Forces medic who is now the chief medical officer of Moderna, one of five drug companies that the US government has identified as finalists in the race for a Covid-19 vaccine, is expressing optimism about the chances that a vaccine will be deployed next year.

“We really expect this to work,” the drug company official, Tal Zaks, said in an online video event this week. He noted the firm had contracted with a manufacturer, and that in 2021, “we expect to be able to make a billion doses.”

Moderna’s vaccine relies on a technology using “messenger RNA,” which Zaks described as “the software of life.” The New York Times reported June 3 that Moderna would be one of five companies chosen as part of the Trump administration’s “warp speed” project to test and deploy a vaccine that would protect against the novel coronavirus. In mid-May, the company announced positive results of an eight-person human trial.

The federal government’s Biomedical Advanced Research and Development Authority has reportedly agreed to provide $483 million to back Moderna’s vaccine development efforts.

Moderna was founded in 2010 and Zaks joined in March 2015, leaving a much larger firm for a young start-up. He said his wife asked him at the time, “What are you doing?” He said he explained at the time that the messenger RNA technology was promising because of its versatility: “If we can make it work, it can work time and time again.”

For example, he said, the firm was also testing its technology against congenital cytomegalovirus, which can cause hearing loss.

In response to a question about when it would be safe for grandparents to visit with their grandchildren, Zaks said he had planned to visit his mother in Israel for Passover, which coincided with her 80th birthday, but the visit was derailed by the pandemic.

“We Skype every weekend,” he said.

Zaks credited “the first-rate education that I got” at Ben-Gurion University of the Negev, but said the story of how Israel put him on his present course “actually starts from the times I was a medic in the IDF.”

As for other drug companies competing in the effort to develop a vaccine, Zaks said: “I have only two competitors in this race — the virus and the clock.”

The phase three trial of the Moderna vaccine is scheduled to being in July, with results “hopefully by the end of the year.”

As for how long a vaccine would last, Zaks said, “we will worry about durability in 2022. If it is a problem, we just give a booster shot.”



https://unitedwithisrael.org/former-idf-medic...+Next+Year
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tuya Smart: AI Powers New Energy Wave at COP31

Updated Category News Views 81

Tuya Smart's Bold Move at COP31 Tuya Smart, a name you don't want to ignore in the world of energy innovation, made a commanding appearance at COP31. Their message was loud and clear: as the climate gets harsher, they're not just sitting around waiting for the next storm. They're arming households with AI-driven solutions. AI-Powered Energy Management Takes Center Stage...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 195

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 34

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 216

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 8

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 13

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
Phoenix Contact Achieves Guinness Record in Wiring

Updated Category News Views 81

A Blitz of Wires and Innovation Boy, did Phoenix Contact shake things up in Blomberg. On a crisp November day, a group of fresh-faced first-year students pulled off something astounding—wiring 500 terminal blocks in a jaw-dropping 2 minutes and 20 seconds. This wasn’t just any effort; it was enough to earn them a shiny new Guinness World Record. What they did wasn’t...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 25

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
Envision and Tsinghua Propel Climate Innovation at COP31

Updated Category News Views 15

Collaborating for a Greener Future On the bustling stage of COP31 in Antalya, Turkey, Envision Energy and Tsinghua University teamed up with the Global Alliance of Universities on Climate (GAUC) to showcase a bold agenda. Their focus transcends mere dialogue, pushing for actionable climate solutions anchored in technological innovation, academic synergy, and the dynamism...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 138

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading

Top 5 Most Recently Viewed Articles

Key Insights on Paragon 28, Inc. Class Action Lawsuit

Updated Category News Views 106

Understanding the Paragon 28 Class Action Lawsuit Recently, investors in Paragon 28, Inc. have been alerted about a significant class action lawsuit involving the company's financial disclosures. The litigation revolves around potential inaccuracies in previously issued financial statements. Investors must be aware that the upcoming deadline to file a lead plaintiff...

Continue Reading
Newtopia Partners with Payvider for Enhanced Health Benefits

Updated Category News Views 278

Newtopia Partners with Payvider for Enhanced Health Benefits Newtopia Inc. (NEWU; NEWUF), a leader in tech-enabled habit change solutions, is thrilled to announce its new partnership with a supplemental insurance payvider. This exciting collaboration aims to provide Newtopia's successful habit change platform as a fully-covered benefit for thousands of workers in the...

Continue Reading
A4A Celebrates 250 Years of American Independence through Aviation

Updated Category News Views 94

A4A Launches Campaign for America's 250th Anniversary Airlines for America (A4A) is excited to unveil a memorable campaign, "Red, Flight & Blue—Celebrating America 250," which aims to celebrate the 250th anniversary of the United States. This significant campaign will utilize a variety of platforms, including social media, blog posts, and videos, to highlight the...

Continue Reading
Alexander’s Secures $400M Loan for New York Office Refinancing

Updated Category News Views 238

ALEXANDER’S, INC. concluded a hefty refinancing deal worth $400 million for its office condominium at 731 Lexington Avenue back in 2024. This isn’t just any property; it’s where Bloomberg LP hangs its hat—a landmark in the bustling New York City real estate scene. Traders were glued to this one because it wasn’t just about refinancing but about what it signals...

Continue Reading
IDV Secures Major Contract for Military Logistics Vehicles

Updated Category News Views 239

IDV Secures a Major Tender from the Dutch Armed Forces In a significant development for military logistics, IDV, part of the renowned Iveco Group (EXM: IVG), has successfully secured a contract with the Dutch Ministry of Defence. This contract entails supplying an impressive fleet of 785 military logistics vehicles, which includes three distinct versions: semitrailer...

Continue Reading